Cargando…

Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States

INTRODUCTION: Thyroid eye disease (TED) is an autoimmune disease that causes retro-orbital inflammation and subsequent proptosis, corneal exposure, strabismus, and variable vision changes. European studies have shown that TED can severely impact quality of life (QOL), but little is known about the Q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yao, Sharma, Anu, Padnick-Silver, Lissa, Francis-Sedlak, Megan, Holt, Robert J., Foley, Colleen, Massry, Guy, Douglas, Raymond S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886952/ https://www.ncbi.nlm.nih.gov/pubmed/33196932 http://dx.doi.org/10.1007/s40123-020-00318-x

Ejemplares similares

Trends in Treatment of Active, Moderate-to-Severe Thyroid Eye Disease in the United States
por: Wang, Yao, et al.
Publicado: (2020)

Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
por: Cockerham, Kimberly P., et al.
Publicado: (2021)

Correction to: Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States
por: Cockerham, Kimberly P., et al.
Publicado: (2022)

Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
por: Francis-Sedlak, Megan, et al.
Publicado: (2020)

SAT-424 Assessing Content Validity of the Graves’ Ophthalmopathy Quality of Life Questionnaire (GO-QOL) in the United States
por: Stan, Marius N, et al.
Publicado: (2020)

Enhancing the Response Rate to Recombinant Uricases in Patients with Gout
por: Schlesinger, Naomi, et al.
Publicado: (2022)

Effect of Leflunomide on Pegloticase Response Rate in Patients with Uncontrolled Gout: A Retrospective Study
por: Masri, Karim Richard, et al.
Publicado: (2022)

Community Practice Experiences with a Variety of Immunomodulatory Agents Co-Administered with Pegloticase for the Treatment of Uncontrolled Gout
por: Broadwell, Aaron, et al.
Publicado: (2022)

Comparison Between Early-Onset and Common Gout: A Systematic Literature Review
por: Amatucci, Anthony J., et al.
Publicado: (2023)

SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019)

Changing the face of thyroid eye disease
por: Ugradar, Shoaib, et al.
Publicado: (2022)

Measuring Health-Related Quality of Life in Thyroid Eye Disease
por: Sharma, Anu, et al.
Publicado: (2022)

Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease
por: Kossler, Andrea Lora, et al.
Publicado: (2022)

Improvement of asymmetric thyroid eye disease with teprotumumab
por: Ugradar, Shoaib, et al.
Publicado: (2022)

Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab
por: Ugradar, Shoaib, et al.
Publicado: (2021)

Teprotumumab for the treatment of chronic thyroid eye disease
por: Ugradar, Shoaib, et al.
Publicado: (2021)

Teprotumumab for thyroid eye disease: early response is not required for benefit
por: Ugradar, Shoaib, et al.
Publicado: (2021)

Lung Cancer Screening Knowledge and Perceived Barriers Among Physicians in the United States
por: Kota, Karthik J., et al.
Publicado: (2022)

Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm
por: Wang, Yao, et al.
Publicado: (2019)

SAT466 Inactive Thyroid Eye Disease Patient Journey
por: Cockerham, Kimberly, et al.
Publicado: (2023)

Perceived Risk of Mosquito-Borne Arboviruses in the Continental United States
por: Lozano, Saul, et al.
Publicado: (2021)

Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study
por: Dikranian, Ara H., et al.
Publicado: (2017)

A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12‐Month Findings
por: Botson, John K., et al.
Publicado: (2023)

The effect of earplugs and eye mask on patients’ perceived sleep quality in intensive care unit
por: Yazdannik, Ahmad Reza, et al.
Publicado: (2014)

Perceived effectiveness of cancer screening among family medicine and internal medicine physicians in the United States
por: Bhurosy, Trishnee, et al.
Publicado: (2022)

Teprotumumab, an insulin-like growth factor-1 receptor antagonist antibody, in the treatment of active thyroid eye disease: a focus on proptosis
por: Douglas, Raymond S.
Publicado: (2018)

MON-501 Physician-Reported Misuse of Thyroid Ultrasound
por: Chen, Debbie W, et al.
Publicado: (2020)

SAT-607 "Eye" Spy with My Big Eye: Thyroid Ophthalmopathy Secondary to Hashitoxicosis
por: Sharma, Pranjali, et al.
Publicado: (2019)

Colorectal Cancer Screening in Ghana: Physicians’ Practices and Perceived Barriers
por: Lussiez, Alisha, et al.
Publicado: (2020)

RF35 | PSAT263 Efficacy of Teprotumumab for Thyroid Eye Disease in Hypothyroid Patients
por: Smith, Terry J, et al.
Publicado: (2022)

Differentiating Urgent and Emergent Causes of Acute Red Eye for the Emergency Physician
por: Gilani, Christopher J., et al.
Publicado: (2017)

How do physicians and nurses differ in their perceived barriers to effective enteral nutrition in the intensive care unit?
por: Mirhosiny, Masoumeh, et al.
Publicado: (2021)

Thyroid eye disease /
por: Char, Devron H., 1945-
Publicado: (1990)

Thyroid Eye Disease
por: Rashad, Ramy, et al.
Publicado: (2022)

Bayesian Analysis of Perceived Eye Level
por: Orendorff, Elaine E., et al.
Publicado: (2016)

Meta-Analysis of Proptosis Response in Thyroid Eye Disease: Efficacy of EUGOGO Recommended Treatment Regimen With IV Methylprednisolone
por: Douglas, Raymond S, et al.
Publicado: (2021)

PSAT261 Use of Steroids Pre- and Post-Teprotumumab in Thyroid Eye Disease Patients
por: Holt, Robert J, et al.
Publicado: (2022)

The Interplay of Work, Digital Health Usage, and the Perceived Effects of Digitalization on Physicians’ Work: Network Analysis Approach
por: Saukkonen, Petra, et al.
Publicado: (2022)

Utility Assessment of Moderate to Severe Thyroid Eye Disease Health States
por: Smith, Terry J., et al.
Publicado: (2022)

Physician variation in perceived barriers to personal health
por: Kosteva, Adam RB, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4mm05gnorbc06clo99en5ibp1l